We read with interest the article by Li and colleagues1 on dexmedetomidine administration for brain tumour resection and postoperative delirium. The primary hypothesis of this randomised trial is that intraoperative dexmedetomidine administration reduces postoperative delirium at 5 days. We believe that some aspects are worthy of further discussion
Dexmedetomidine administration during brain tumour resection and postoperative delirium: a randomised controlled trial. Comment on Br J Anaesth 2023; 130: e307-e316 / Akça, Başak; Salaj, Charlotte S; Bilotta, Federico. - In: BRITISH JOURNAL OF ANAESTHESIA. - ISSN 0007-0912. - (2023), pp. 1-2. [10.1016/j.bja.2023.04.012]
Dexmedetomidine administration during brain tumour resection and postoperative delirium: a randomised controlled trial. Comment on Br J Anaesth 2023; 130: e307-e316
Bilotta, Federico
2023
Abstract
We read with interest the article by Li and colleagues1 on dexmedetomidine administration for brain tumour resection and postoperative delirium. The primary hypothesis of this randomised trial is that intraoperative dexmedetomidine administration reduces postoperative delirium at 5 days. We believe that some aspects are worthy of further discussionI documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
